# Doxycycline for COPD in HIV-Infected Patients

> **NCT01744093** · NA · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 61 (actual)

## Conditions studied

- HIV
- Chronic Obstructive Pulmonary Disease (COPD)
- Emphysema

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** Placebo (sugar pill)

## Key facts

- **NCT ID:** NCT01744093
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-08
- **Primary completion:** 2017-06-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2022-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01744093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01744093, "Doxycycline for COPD in HIV-Infected Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01744093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*